These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35776660)

  • 1. ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver.
    Schmid CD; Olsavszky V; Reinhart M; Weyer V; Trogisch FA; Sticht C; Winkler M; Kürschner SW; Hoffmann J; Ola R; Staniczek T; Heineke J; Straub BK; Mittler J; Schledzewski K; Ten Dijke P; Richter K; Dooley S; Géraud C; Goerdt S; Koch PS
    Hepatology; 2023 Apr; 77(4):1211-1227. PubMed ID: 35776660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity.
    Anzell AR; Kunz AB; Donovan JP; Tran TG; Lu X; Young S; Roman BL
    Angiogenesis; 2024 Aug; 27(3):501-522. PubMed ID: 38727966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
    Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
    Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
    Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
    Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
    Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
    Kim JH; Peacock MR; George SC; Hughes CC
    Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Park H; Furtado J; Poulet M; Chung M; Yun S; Lee S; Sessa WC; Franco CA; Schwartz MA; Eichmann A
    Circulation; 2021 Sep; 144(10):805-822. PubMed ID: 34182767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
    Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
    Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.
    Capasso TL; Li B; Volek HJ; Khalid W; Rochon ER; Anbalagan A; Herdman C; Yost HJ; Villanueva FS; Kim K; Roman BL
    Angiogenesis; 2020 May; 23(2):203-220. PubMed ID: 31828546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP9 is a key player in endothelial identity and its loss is sufficient to induce arteriovenous malformations.
    Desroches-Castan A; Koca D; Liu H; Roelants C; Resmini L; Ricard N; Bouvard C; Chaumontel N; Tharaux PL; Tillet E; Battail C; Lenoir O; Bailly S
    Cardiovasc Res; 2024 May; 120(7):782-795. PubMed ID: 38502919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2.
    Choi EJ; Kim YH; Choe SW; Tak YG; Garrido-Martin EM; Chang M; Lee YJ; Oh SP
    PLoS One; 2013; 8(5):e63138. PubMed ID: 23675457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations.
    Ricard N; Bidart M; Mallet C; Lesca G; Giraud S; Prudent R; Feige JJ; Bailly S
    Blood; 2010 Sep; 116(9):1604-12. PubMed ID: 20501893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
    Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
    Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
    Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
    Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.